Open AccessThe use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients
Author(s) -
Rosa Zampino,
Rita Lebano,
Nicola Coppola,
Margherita Macera,
Anna Grandone,
Luca Rinaldi,
Ilario de Sio,
Antonella Tufano,
Gianfranca Stornaiuolo,
Luigi Elio Adinolfi,
Emanuele DuranteMangoni,
Gaeta G Battista,
Alferio Niglio
Publication year - 2018
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/sjg.sjg_100_17
Subject(s) - medicine , portal vein thrombosis , gastroenterology , beta (programming language) , thrombosis , risk factor , computer science , programming language
A reduction in portal vein inflow velocity seems to predispose to the emergence of portal vein thrombosis (PVT). Nonselective β-blockers (NSBBs), used to prevent variceal bleeding, may increase the development of PVT by reducing portal vein inflow velocity. In this retrospective case-control study, we evaluated the risk factors and clinical features of a first event of PVT in 130 cirrhotics, 19 (15%) with (PVT group) and 111 (85%) without PVT (non-PVT group).